Industries
Every US-listed company grouped by sector and industry. Drill from sectors into industry groups and individual industries to compare returns, breadth and momentum.
Close 2026-10-14 · S&P 500 1D −1.08%
Companies
318
Market cap
$5.75T
1D cap-weighted
+2.47%
1D median stock
−0.51%
1D vs S&P
+3.55%
Above 200-day
40%
52-wk highs / lows
4 / 31
Median RSI
37
LLY+3.6%JNJ+2.1%ABBV+3.3%MRK+3.8%NVS+3.1%AZN+4.0%ABT+0.3%NVO+0.2%PFE+3.0%VRTX+2.7%BMY+4.6%SNY+1.7%GSK+3.5%REGN+3.4%TAK+2.6%TEVA−1.3%ONC+0.7%ZTS+1.3%ALNY+0.3%RPRX+4.3%ROIV+0.8%UTHR−0.6%GMAB+0.9%INSM+1.0%VTRS+1.1%ASND+1.7%JAZZ−0.3%CORT−1.3%SMMT−2.5%BBIO+2.6%ELAN+0.6%RDY−0.2%BMRN+1.4%MDGL+1.8%PTGX−1.6%CYTK+2.9%TGTX+0.1%ARWR+0.4%AXSM+3.8%ABVX+2.0%SYRE−2.3%IONS+0.8%AMRX−3.4%PRAX−1.8%ALKS−1.6%KNSA+0.4%BLTE+0.6%LGND−2.8%RYTM+0.1%ORKA−1.9%MIRM+0.4%ERAS−0.5%PTCT−0.4%TVTX+2.8%GRFS+1.0%COGT+0.2%MANE−2.4%DNTH−3.6%INDV−3.6%ABCL−1.9%EWTX+2.0%TNGX−0.1%TLX−2.5%OGN−0.2%LEGN+6.5%VKTX−4.4%AMLX+0.7%XENE−1.5%PBLS−3.6%IDYA−1.2%ARQT+1.2%ACAD+3.4%ELVN−0.5%RCUS+0.1%DYN−1.7%PGEN−1.7%ZLAB−2.6%SLS−4.3%SUPN−4.4%NRIX+7.0%NAMS−0.9%LQDA+26.6%MBX−0.4%HCM−0.1%PBH−0.2%BHC0.0%AUPH+1.5%IRON−1.5%HRMY+1.3%PRGO+3.8%PHVS0.0%IMNM−2.2%VRDN+0.9%SDGR−3.2%VERA−0.2%LKFT+1.2%ADRX+0.7%URGN−4.4%XERS−4.2%MLYS−1.1%PVLA−4.6%AGIO+2.5%ZYME−1.2%TRVI−1.9%XNCR−0.6%SRPT+1.9%BHVN−4.3%SEPN−0.3%NUVB−0.8%ZBIO−1.2%ANIP−1.0%GPCR−1.9%OCUL−0.6%GENB+2.2%CMPS+1.2%ETON−0.8%INVA+1.1%PAHC+3.0%QURE−1.5%RARE−0.1%STOK+3.4%PCRX+0.3%KRSA+8.4%AAPG−1.4%KLRA−0.3%RAPP−2.3%OMER−2.4%ANAB+2.4%NKTR−2.7%GHRS−1.5%TYRA+0.8%SNDX−3.0%KARD+4.2%ORIC+2.5%BCAX0.0%DMRA−0.7%TRAX+7.7%LBRX−2.3%AMPH+0.1%NBTX−1.0%HROW−3.5%AVLN−0.2%JANX−0.3%OPK+3.8%SVRA−0.4%MNKD−1.0%MRVI+0.3%AKTS−0.9%MLTX−2.6%RIGL−0.7%KURA−2.2%ANRO−1.7%SPTX+3.7%CYRX−1.8%JBIO+0.1%ALMS−7.6%ABUS+1.9%ARDX+2.2%AVBP+0.7%CRVS−0.3%GERN−0.8%HELP−1.1%ANL−7.4%APMD−3.4%OBX+1.9%ANNX−4.2%IMMX−2.1%LXRX−0.6%GYRE−3.6%COLL+4.5%IVA0.0%VSTM+3.5%PHAR+2.1%AVTX−1.4%WVE−1.6%ZVRA−1.5%OLMA−3.1%DSGN−0.5%IRWD+0.3%NVCT−0.8%CLYM−0.2%AQST−1.3%CRMD0.0%PHAT+5.7%SGMT−5.5%FTH−7.0%SLN+1.2%STTK−2.9%PBYI+0.8%ACRS−2.6%DRUG−1.3%CTMX−4.1%EOLS−3.9%MNPR+1.4%CBIO−2.6%EVO+6.0%ALT−4.9%OCS−5.9%ARVN−0.3%RZLT−8.2%KMDA−1.2%EPRX−1.4%MPLT−0.8%NGNE+2.9%PRTA+0.1%OVID0.0%DMAC−2.0%PRE−3.1%ASMB+0.9%SPRY−3.0%CAPR−4.2%AVIR−7.0%GALT−1.4%RLMD−3.6%EBS0.0%IRD−3.3%ARCT−7.6%ENTA−3.0%TTRX+4.8%INDP−7.5%CTNM−3.3%CYPH−7.8%BNTC−3.9%AMGN+3.2%GILD+3.8%MRNA+4.7%ARGX+1.9%RVMD+2.7%BIIB+1.7%BNTX−0.4%EXEL+2.5%NBIX+0.6%HALO+6.6%TECH+0.0%RGEN+1.6%PCVX+1.1%IBRX+1.1%TWST−2.1%KRYS+3.0%QGEN+0.3%KYMR+0.1%IOVA−2.0%IMVT−2.8%KOD−11.5%CGON−0.9%SRRK−2.3%CRSP+0.2%ADPT+1.3%RLAY−1.7%TARS+2.1%DNLI−2.9%BEAM−3.2%ADMA+0.3%NVAX−1.4%VCEL−0.1%BCRX−0.3%RXRX−2.5%ALVO−3.9%MESO−0.8%VIR−1.9%MAZE−1.6%IMCR+1.9%COAG+0.5%INBX−2.1%TSHA−2.0%REPL−6.0%VOR−1.6%IMTX+2.5%MGTX−5.3%CGEM−3.3%SLBT+1.3%GLUE−0.5%ODTX−3.7%DNA−2.0%SANA−3.3%CADL−2.2%FDMT−1.3%ATTO+1.6%AURA−1.6%SLDB−6.1%PRME−5.7%DBVT−1.8%ETRA+3.8%VALN+1.8%RGNX−5.2%ALLO+0.8%AGMB−1.4%ENTX+0.4%AUTL+4.3%TECX−1.6%ZURA+4.3%EDIT−7.2%TRXB−0.7%EIKN+4.3%SCTX+8.6%FENC−2.0%KYTX−1.5%CCCC−6.1%PROK−6.4%AGEN−6.5%ARTV−6.0%OCGN−5.0%In Vitro and in Vivo Diagnostic Substances+1.1%
Tiles are sized by market cap and coloured by return over the chosen period. Click a group or tile to drill in; click a company for its quote. Search for a company to see where it sits.
Industries in Drugs
| Industry | Companies | Market cap | 1D | Median stock | Up today | > 50-day | > 200-day | 52-wk hi / lo | RSI |
|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Preparations2834 | 223 | $4.82T | +2.51% | −0.32% | 41% | 19% | 37% | 3 / 22 | 36 |
| Biological Products, except Diagnostic Substances2836 | 79 | $857B | +2.36% | −0.90% | 42% | 25% | 49% | 1 / 7 | 39 |
| In Vitro and in Vivo Diagnostic Substances2835 | 9 | $56.5B | +1.11% | −0.02% | 33% | 44% | 44% | 0 / 0 | 46 |
| Medicinal Chemicals and Botanical Products2833 | 7 | $13.0B | −1.21% | −1.38% | 0% | 14% | 25% | 0 / 2 | 36 |
Return follows the weighting above. Up today, above the 50- and 200-day averages: share of companies. 52-week: companies at a new 52-week high / low today.
Largest companies in Drugs
100 of 318| Symbol | Name | Market cap | 1D | 1M | YTD | 1Y | RSI | > 50-day | > 200-day | 52-wk |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co. | $1.04T | +3.62% | +6.39% | +12.47% | +47.52% | 60 | ✓ | ✓ | |
| JNJ | Johnson & Johnson | $599B | +2.13% | −4.97% | +22.69% | +33.01% | 41 | ✓ | ||
| ABBV | Abbvie Inc. | $485B | +3.32% | +7.77% | +24.07% | +23.09% | 70 | ✓ | ✓ | High |
| MRK | Merck & Co., Inc. | $350B | +3.80% | +2.49% | +40.01% | +71.96% | 55 | ✓ | ✓ | |
| NVS | Novartis AG | $271B | +3.14% | +5.96% | +6.54% | +13.75% | 56 | |||
| AZN | AstraZeneca PLC | $242B | +3.99% | +0.11% | +76.25% | +91.73% | 51 | ✓ | ||
| AMGN | Amgen Inc | $223B | +3.21% | +13.43% | +30.19% | +45.73% | 60 | ✓ | ✓ | |
| GILD | Gilead Sciences Inc | $183B | +3.80% | +4.95% | +25.09% | +29.89% | 61 | ✓ | ✓ | |
| ABT | Abbott Laboratories | $178B | +0.35% | +0.92% | −17.81% | −21.62% | 54 | |||
| NVO | Novo-Nordisk A/S | $168B | +0.16% | −10.37% | −25.08% | −33.70% | 36 | |||
| PFE | Pfizer Inc. | $162B | +2.96% | +6.03% | +17.31% | +18.12% | 66 | ✓ | ✓ | High |
| VRTX | Vertex Pharmaceuticals Inc | $123B | +2.74% | −3.13% | +9.96% | +22.37% | 42 | ✓ | ||
| BMY | Bristol-Myers Squibb Co. | $116B | +4.61% | −6.98% | +9.90% | +36.15% | 42 | |||
| SNY | Sanofi | $93.7B | +1.66% | −6.20% | −17.93% | −18.50% | 37 | |||
| GSK | GSK plc | $92.7B | +3.46% | −4.28% | −2.39% | +9.57% | 47 | |||
| MRNA | Moderna, Inc. | $86.3B | +4.65% | +57.40% | +667.38% | +746.30% | 69 | ✓ | ✓ | |
| REGN | Regeneron Pharmaceuticals Inc | $77.5B | +3.35% | +0.55% | +0.84% | +39.56% | 54 | ✓ | ||
| TAK | Takeda Pharmaceutical Company Limited | $59.2B | +2.65% | +1.66% | +21.94% | +38.56% | 61 | ✓ | ✓ | |
| ARGX | argenx SE | $50.5B | +1.95% | −16.48% | −2.69% | +2.34% | 29 | |||
| TEVA | Teva Pharmaceutical Industries Limited | $48.1B | −1.28% | +3.75% | +30.47% | +103.40% | 61 | ✓ | ✓ | |
| IDXX | Idexx Laboratories Inc | $41.0B | +1.67% | +3.58% | −21.81% | −16.47% | 53 | |||
| RVMD | Revolution Medicines, Inc. | $40.4B | +2.70% | −5.54% | +142.96% | +296.96% | 45 | ✓ | ||
| ONC | BeOne Medicines Ltd. | $39.5B | +0.69% | +1.44% | +15.69% | +7.48% | 46 | ✓ | ||
| BIIB | Biogen Inc. | $33.8B | +1.72% | +7.71% | +32.30% | +60.92% | 64 | ✓ | ✓ | |
| ZTS | Zoetis Inc. | $30.7B | +1.33% | +2.53% | −40.16% | −47.08% | 59 | ✓ | ||
| ALNY | Alnylam Pharmaceuticals, Inc. | $29.9B | +0.29% | −5.79% | −43.55% | −51.72% | 40 | |||
| RPRX | Royalty Pharma plc | $25.2B | +4.28% | +0.89% | +52.67% | +66.45% | 55 | ✓ | ||
| ROIV | Roivant Sciences Ltd. | $24.1B | +0.81% | −14.89% | +54.93% | +107.40% | 37 | ✓ | ||
| UTHR | United Therapeutics Corp | $23.3B | −0.62% | +7.93% | +10.83% | +22.72% | 56 | ✓ | ✓ | |
| GMAB | Genmab A/S | $22.5B | +0.88% | +8.02% | +19.77% | +12.88% | 59 | ✓ | ✓ | |
| BNTX | BioNTech SE | $22.4B | −0.39% | −8.30% | −6.87% | −13.33% | 35 | |||
| INSM | Insmed, Inc. | $21.1B | +1.03% | −18.45% | −43.81% | −40.35% | 29 | |||
| VTRS | Viatris Inc. | $19.8B | +1.10% | +4.74% | +40.08% | +76.88% | 53 | ✓ | ✓ | |
| EXEL | Exelixis Inc | $14.7B | +2.49% | +7.19% | +39.15% | +58.66% | 66 | ✓ | ✓ | |
| ASND | Ascendis Pharma A/S Ordinary Share | $14.7B | +1.70% | −5.33% | +6.45% | +8.91% | 43 | |||
| NBIX | Neurocrine Biosciences Inc | $13.7B | +0.58% | −9.41% | −4.17% | −1.05% | 34 | |||
| JAZZ | Jazz Pharmaceuticals, Inc. | $13.7B | −0.35% | −12.95% | +23.32% | +55.14% | 22 | |||
| CORT | Corcept Therapeutics Inc. | $12.7B | −1.33% | +4.88% | +233.99% | +62.49% | 50 | ✓ | ✓ | |
| HALO | Halozyme Therapeutics, Inc. | $12.4B | +6.57% | +9.95% | +73.58% | +78.82% | 64 | ✓ | ✓ | High |
| SMMT | Summit Therapeutics Inc. | $12.4B | −2.51% | −13.05% | −13.49% | −34.02% | 41 | |||
| BBIO | BridgeBio Pharma, Inc. | $12.4B | +2.59% | −5.04% | −15.10% | +16.05% | 38 | |||
| TECH | Bio-Techne Corp. | $11.4B | +0.03% | +0.22% | +23.28% | +21.54% | 56 | ✓ | ✓ | |
| ELAN | Elanco Animal Health Incorporated | $11.2B | +0.62% | −1.96% | −0.35% | +12.52% | 47 | |||
| RGEN | Repligen Corp | $11.1B | +1.58% | +1.99% | +8.75% | +19.86% | 51 | ✓ | ✓ | |
| RDY | Dr. Reddy's Laboratories Limited | $10.6B | −0.16% | +10.39% | −9.19% | −11.21% | 59 | ✓ | ||
| BMRN | BioMarin Pharmaceuticals Inc | $10.5B | +1.40% | −14.45% | −7.22% | +5.13% | 30 | |||
| PCVX | Vaxcyte, Inc. | $10.5B | +1.12% | +14.09% | +46.40% | +54.19% | 58 | ✓ | ✓ | |
| MDGL | Madrigal Pharmaceuticals, Inc. | $10.4B | +1.75% | −12.09% | −21.01% | +7.55% | 28 | |||
| IBRX | ImmunityBio, Inc. | $10.4B | +1.12% | +21.74% | +400.51% | +299.60% | 59 | ✓ | ✓ | |
| TWST | Twist Bioscience Corporation | $10.0B | −2.09% | +7.28% | +367.09% | +391.57% | 45 | ✓ | ✓ | |
| KRYS | Krystal Biotech, Inc. | $9.51B | +2.97% | −1.78% | +34.13% | +79.00% | 47 | ✓ | ||
| QGEN | Qiagen N.V. | $9.38B | +0.26% | +7.25% | +1.31% | −3.52% | 57 | ✓ | ✓ | |
| PTGX | Protagonist Therapeutics, Inc | $8.96B | −1.60% | −4.97% | +56.03% | +72.14% | 40 | ✓ | ||
| KYMR | Kymera Therapeutics, Inc. | $8.87B | +0.14% | −5.59% | +37.30% | +78.38% | 41 | ✓ | ||
| CYTK | Cytokinetics Inc. | $8.57B | +2.94% | −8.48% | −0.17% | +6.44% | 39 | |||
| TGTX | TG Therapeutics, Inc. | $8.32B | +0.06% | +2.51% | +82.39% | +58.88% | 49 | ✓ | ✓ | |
| ARWR | Arrowhead Research Corporation | $8.21B | +0.41% | −17.40% | −12.08% | +61.02% | 27 | |||
| AXSM | Axsome Therapeutics, Inc | $8.19B | +3.77% | −20.51% | −11.18% | +33.90% | 27 | |||
| ABVX | Abivax SA | $7.52B | +2.04% | −17.51% | −34.76% | −8.00% | 34 | |||
| SYRE | Spyre Therapeutics, Inc. | $7.52B | −2.26% | −13.55% | +140.02% | +315.70% | 37 | ✓ | ||
| IONS | Ionis Pharmaceuticals, Inc. | $7.04B | +0.76% | −9.63% | −46.02% | −39.51% | 35 | Low | ||
| AMRX | Amneal Pharmaceuticals, Inc. | $6.82B | −3.42% | +13.51% | +50.00% | +93.85% | 46 | ✓ | ✓ | |
| PRAX | Praxis Precision Medicines, Inc. | $6.79B | −1.78% | −23.61% | −18.90% | +356.67% | 22 | |||
| ALKS | Alkermes Inc. plc | $6.67B | −1.64% | −15.10% | +39.67% | +21.48% | 31 | |||
| IOVA | Iovance Biotherapeutics, Inc. | $6.57B | −2.00% | +51.82% | +420.51% | +564.02% | 69 | ✓ | ✓ | |
| LNTH | Lantheus Holdings, Inc | $6.53B | −0.02% | −0.72% | +50.26% | +83.18% | 46 | ✓ | ||
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.13B | +0.39% | +4.91% | +91.13% | +112.91% | 57 | ✓ | ✓ | |
| BLTE | Belite Bio, Inc | $6.12B | +0.56% | −9.87% | −4.53% | +91.45% | 39 | |||
| LGND | Ligand Pharmaceuticals Inc. | $6.05B | −2.81% | +6.50% | +56.02% | +63.98% | 48 | ✓ | ✓ | |
| RYTM | Rhythm Pharmaceuticals, Inc. | $5.96B | +0.12% | −10.40% | −18.99% | −13.95% | 26 | |||
| IMVT | Immunovant, Inc. | $5.93B | −2.82% | −23.87% | +9.76% | +60.81% | 15 | |||
| KOD | Kodiak Sciences Inc | $5.76B | −11.50% | +145.80% | +190.02% | +599.05% | 59 | ✓ | ✓ | |
| CGON | CG Oncology, Inc. | $5.53B | −0.90% | −14.76% | +48.94% | +43.95% | 33 | |||
| ORKA | Oruka Therapeutics, Inc. | $5.18B | −1.93% | −16.83% | +152.99% | +200.65% | 33 | ✓ | ||
| MIRM | Mirum Pharmaceuticals, Inc. | $5.17B | +0.43% | −14.85% | +1.23% | +10.79% | 34 | |||
| ERAS | Erasca, Inc. | $5.17B | −0.54% | −9.54% | +295.16% | +512.50% | 45 | ✓ | ||
| PTCT | PTC Therapeutics, Inc. | $5.00B | −0.42% | −9.11% | −21.45% | −9.67% | 33 | Low | ||
| SRRK | Scholar Rock Holding Corporation | $4.93B | −2.27% | −20.80% | −10.10% | +15.54% | 25 | |||
| TVTX | Travere Therapeutics, Inc. | $4.88B | +2.84% | −14.78% | +39.41% | +103.32% | 34 | ✓ | ||
| GRFS | Grifois, S.A. | $4.88B | +0.98% | −1.63% | −22.57% | −23.39% | 41 | |||
| COGT | Cogent Biosciences, Inc. | $4.87B | +0.21% | −14.02% | −20.75% | +73.77% | 28 | |||
| MANE | Veradermics, Incorporated | $4.86B | −2.40% | +9.22% | — | — | 49 | ✓ | — | |
| CRSP | CRISPR Therapeutics AG | $4.84B | +0.24% | −3.11% | −4.23% | −26.46% | 40 | |||
| DFTX | Definium Therapeutics, Inc. | $4.62B | −0.41% | −7.01% | — | — | 38 | — | ||
| DNTH | Dianthus Therapeutics, Inc. | $4.34B | −3.63% | −28.64% | +81.41% | +117.20% | 16 | |||
| INDV | Indivior Pharmaceuticals, Inc. | $4.18B | −3.56% | −0.18% | −4.79% | +43.11% | 38 | |||
| ABCL | AbCellera Biologics Inc. | $4.09B | −1.90% | +8.41% | +261.70% | +118.17% | 49 | ✓ | ✓ | |
| RGC | Regencell Bioscience Holdings Limited | $4.06B | −0.98% | +44.82% | −61.38% | −54.92% | 69 | ✓ | ||
| ADPT | Adaptive Biotechnologies Corporation | $4.03B | +1.34% | −3.97% | +57.76% | +65.29% | 44 | ✓ | ||
| EWTX | Edgewise Therapeutics, Inc. | $3.94B | +2.04% | −15.15% | +49.18% | +151.67% | 34 | ✓ | ||
| RLAY | Relay Therapeutics, Inc. | $3.80B | −1.73% | −10.07% | +101.65% | +172.09% | 39 | ✓ | ||
| TNGX | Tango Therapeutics, Inc. | $3.75B | −0.14% | −7.12% | +150.45% | +161.98% | 43 | ✓ | ||
| TLX | Telix Pharmaceuticals Limited | $3.71B | −2.47% | −16.99% | +42.19% | +11.64% | 43 | ✓ | ||
| OGN | Organon & Co. | $3.62B | −0.22% | +0.59% | +91.63% | +43.13% | 52 | ✓ | ✓ | |
| LEGN | Legend Biotech Corporation | $3.48B | +6.49% | +7.75% | −12.42% | −42.04% | 50 | |||
| VKTX | Viking Therapeutics, Inc | $3.39B | −4.43% | −14.96% | −27.60% | −24.89% | 34 | Low | ||
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.37B | +0.67% | −18.46% | +123.76% | +91.43% | 38 | ✓ | ||
| XENE | Xenon Pharmaceuticals Inc | $3.33B | −1.51% | −39.77% | −24.36% | −15.23% | 20 | Low | ||
| PBLS | Parabilis Medicines, Inc. | $3.32B | −3.58% | −27.52% | — | — | 30 | — | ||
| TARS | Tarsus Pharmaceuticals, Inc. | $3.31B | +2.08% | −7.59% | −11.71% | +2.77% | 44 | ✓ |
How the industry explorer works
Industries. Each company is placed by the Standard Industrial Classification (SIC) code it reports in its SEC filings, then grouped into one of 11 sectors. SIC has three levels below the sector: major groups (two digits, e.g. 28 Chemicals), industry groups (three digits, e.g. 283 Drugs) and industries (four digits, e.g. 2834 Pharmaceutical Preparations). Codes ending in 0 or 00 mean a company is classified at the group level only; those appear as "(general)". Groups with a single sub-group are merged so every drill step shows a choice.
Cap-weighted vs median. The cap-weighted return is how the group performed as a basket, so the largest companies dominate it. The median stock shows what a typical member did. A wide gap between the two means a few giants are carrying, or dragging, the group.
Companies, not tickers. A company with several share classes (Alphabet, Berkshire) counts once, through its most traded class. Blank-check companies (SPACs) are left out. Use the size filter to drop micro-caps, which dominate the counts in industries like biotech.
Find a company. Search by ticker or name to jump to the industry a company is classified in. It stays marked on the map and its path stays above the figures while you move between levels, so you can see which sector, group and industry it belongs to and how it ranks there. Funds and ETFs have no industry and are not on the map.
Figures are price returns (excluding dividends) as of the latest close, refreshed each trading day after the market closes. The S&P 500 comparison uses SPY over the same period.